Press release
Key Influencer in the Inherited Retinal Disease Market 2025: Rising Macular Degeneration Cases Boost Market Growth Driver
Inherited Retinal DiseaseMarket Size
The rising occurrence of macular degeneration is anticipated to fuel the expansion of the inherited retinal disease market in the future. Macular degeneration, an age-associated eye disorder that impairs the macula, results in central vision loss and difficulties with tasks such as reading or identifying faces. This growing incidence of macular degeneration is facilitated by aging demographics, increased life span, and lifestyle elements like smoking and inadequate nutrition, which heighten the risk. Inherited retinal disease treatments support macular degeneration patients by addressing the genetic roots of retinal degeneration, offering therapies that impede disease development, restore lost sight, or even forestall further harm to the retina, ultimately enhancing visual outcomes and life quality for those afflicted by age-related or inherited kinds of macular degeneration. For instance, in February 2024, according to the Canadian Ophthalmological Society, a nonprofit organization based in Canada, indicated that 2.5 million individuals in Canada over 55 years of age lose their sight due to age-related macular degeneration (AMD). Consequently, the escalating prevalence of macular degeneration is stimulating the growth of the inherited retinal disease market.
Get Your Inherited Retinal Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report
What is the future CAGR of the inherited retinal disease market, and how will it impact industry expansion?
In recent times, the inherited retinal disease market has seen significant growth. The market value, which stands at $11.56 billion in 2024, is projected to expand to $12.58 billion in 2025, thanks to a compound annual growth rate (CAGR) of 8.8%. The impressive growth recorded during the historic period has been spurred by factors such as the development and increased adoption of gene therapy, regulatory benefits, a surge in patient registries, an increase in clinical trials, and a rise in patient-focused solutions.
The market size for inherited retinal disease is projected to experience robust expansion in the upcoming years. The market is anticipated to reach $17.42 billion in 2029, with a compound annual growth rate (CAGR) of 8.5%. Factors contributing to the projected growth during the forecast period include a growing utilization of CRISPR, the rise of custom treatments, an emphasis on regenerative medicine, an increase in patient advocacy, and a focus on enhancing the quality of life for patients. Key trends predicted for the forecast period involve progresses in optogenetics technology, the creation of artificial retina implants, the broadening of digital health platforms, the application of artificial intelligence in disease modeling, as well as the use of artificial intelligence in shaping treatment plans.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp
What new trends are reshaping the inherited retinal disease market and its opportunities?
Leading firms in the inherited retinal diseases market are prioritizing the creation of novel treatment strategies, such as mutation-agnostic gene therapy. This approach provide comprehensive solutions and cater to a wider array of genetic variations related to these diseases. Mutation-agnostic gene therapy targets extensive genetic mechanisms or pathways rather than focusing on specific mutations. This makes it suitable for treating a range of genetic disorders. For instance, in March 2024, a significant breakthrough was announced by Nanoscope Therapeutics Inc., an American biotechnology business. Positive clinical trial outcomes were reported for its main program, MCO-010, which provided improved vision for patients suffering from advanced retinitis pigmentosa, a condition that causes severe and irreversible vision loss. MCO-010 successfully achieved its primary and crucial secondary endpoints with statistically significant results and no severe adverse events.
Which key market segments comprise the inherited retinal disease market and drive its revenue growth?
The inherited retinal disease market covered in this report is segmented -
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users
Subsegments,
1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20850
What regions are at the forefront of inherited retinal disease market expansion?
North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the inherited retinal disease market?
Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp
What Is Covered In The Inherited Retinal Disease Global Market Report?
•Market Size Forecast: Examine the inherited retinal disease market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the inherited retinal disease market for a structured understanding.
•Key Players Overview: Analyze major players in the inherited retinal disease market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the inherited retinal disease market.
•Segment Contributions: Evaluate how different segments drive overall growth in the inherited retinal disease market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the inherited retinal disease market.
•Industry Challenges: Identify potential risks and obstacles affecting the inherited retinal disease market.
•Competitive Landscape: Review strategic developments in the inherited retinal disease market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Inherited Retinal Disease Market 2025: Rising Macular Degeneration Cases Boost Market Growth Driver here
News-ID: 3944779 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Retina
Visual Prosthesis Market | Bionic Vision, Nano Retina, PIXIUM VISION, Retina Imp …
The global visual prosthesis market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the visual prosthesis market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Artificial Retina Market Revenue 2019: Nano-Retina, Second Sights
Product innovation is a key artificial retina market trend. The ophthalmic industry has become more competitive over the last few years. Established ophthalmic product categories have become more mature, in turn offering low level of market opportunity for players. Most companies are emphasizing on price level strategy in order to enhance their business presence worldwide. However, the pricing trend could potentially benefit the company on a shorter scale during the…
Artificial Retina Market Key Players – Second Sight, Nano Retina, Retina Impla …
Artificial Retina manufacturers are making huge financial investments in R&D which is leading to new and innovative product development resulting in driving the growth for the market in turn. According to a recent study report published by the Market Research Future, The Global Market of Artificial Retina is growing steadily and is expected to continue its growth soon. Global Artificial Retina Market is expected to grow to US$ 102.9 million…
Artificial Retina Market 2018: Advancement with Key Player – Second Sight, Nan …
Artificial Retina is new hope for blind people and helps blind person to see objects. Artificial retina is placed either in the internal surface of the retina or outer surface of retina. There are around 1.5 million people suffering from retinitis pigmentosa which ultimately causes blindness. Approximately, 280 million people with visual impairment and about 40 million people are completely blind.
Global Artificial Retina Market - Key Players
Some of the…
Artificial Retina Market Insights With Key Players Nano-Retina, Second Sights, a …
Artificial retina market is a major breakthrough in medical devices industry, wherein many universities and leading medical devices companies are conducting research to offer vision to over 285 million visually impaired population worldwide. These devices are mainly nanorod carbon nanotube biomimetic films along with accessory devices such as transmitter and video processing unit (VPU). As such progressive development towards artificial retina is expected to create high ROI for engaged…
Artificial Retina Market Unique Scenario by Key Vendors Like: Second Sight, Nano …
Global Market for Artificial Retina is growing steady and expected to continue its growth near future. Global Artificial Retina Market is expected to grow US$ 102.9 million by 2023 at CAGR of 2.1%.
Global Artificial Retina Market - Key Players
Some of the key players in this market are:
Second Sight (US)
Nano Retina (Israel)
Retina Implant AG (Germany)
Pixium Vision (France)
Bionic Vision Australia
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2812
Global Artificial Retina Market - Segments
Global Artificial Retina…
